David Moffat
South Australia Pathology(AU)Flinders University(AU)Flinders Medical Centre(AU)Redx Pharma (United Kingdom)(GB)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Lung Cancer Treatments and Mutations, Lung Cancer Research Studies, Lung Cancer Diagnosis and Treatment, Pleural and Pulmonary Diseases
Most-Cited Works
- → Escaping from Flatland: clinical and biological aspects of human mammary duct anatomy in three dimensions(2004)176 cited
- → Intra- and Interobserver Reproducibility Assessment of PD-L1 Biomarker in Non–Small Cell Lung Cancer(2017)135 cited
- → Cirrhosis with steatohepatitis after adjuvant tamoxifen(1999)115 cited
- → Discovery of 2-(6-{[(6-Fluoroquinolin-2-yl)methyl]amino}bicyclo[3.1.0]hex-3-yl)-N-hydroxypyrimidine-5-carboxamide (CHR-3996), a Class I Selective Orally Active Histone Deacetylase Inhibitor(2010)83 cited
- → Review of diagnostic error in anatomical pathology and the role and value of second opinions in error prevention(2018)74 cited
- → Drug Targeting to Monocytes and Macrophages Using Esterase-Sensitive Chemical Motifs(2011)69 cited